[go: up one dir, main page]

WO2008010042A3 - Procédé amélioré pour la préparation d'un intermédiaire de la céfépime - Google Patents

Procédé amélioré pour la préparation d'un intermédiaire de la céfépime Download PDF

Info

Publication number
WO2008010042A3
WO2008010042A3 PCT/IB2007/001897 IB2007001897W WO2008010042A3 WO 2008010042 A3 WO2008010042 A3 WO 2008010042A3 IB 2007001897 W IB2007001897 W IB 2007001897W WO 2008010042 A3 WO2008010042 A3 WO 2008010042A3
Authority
WO
WIPO (PCT)
Prior art keywords
preparation
cefepime
improved process
compound
formula
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/IB2007/001897
Other languages
English (en)
Other versions
WO2008010042A2 (fr
Inventor
Sureshkumar Kanagaraj
Mohan Singaravel
Narayanan Arunkumar Lakshmi
Palanisamy Senth Udayampalayam
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Orchid Pharma Ltd
Original Assignee
Orchid Chemicals and Pharmaceuticals Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Orchid Chemicals and Pharmaceuticals Ltd filed Critical Orchid Chemicals and Pharmaceuticals Ltd
Publication of WO2008010042A2 publication Critical patent/WO2008010042A2/fr
Publication of WO2008010042A3 publication Critical patent/WO2008010042A3/fr
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/04Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D501/00Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C07D501/02Preparation
    • C07D501/04Preparation from compounds already containing the ring or condensed ring systems, e.g. by dehydrogenation of the ring, by introduction, elimination or modification of substituents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D501/00Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C07D501/14Compounds having a nitrogen atom directly attached in position 7
    • C07D501/16Compounds having a nitrogen atom directly attached in position 7 with a double bond between positions 2 and 3
    • C07D501/187-Aminocephalosporanic or substituted 7-aminocephalosporanic acids
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D501/00Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C07D501/14Compounds having a nitrogen atom directly attached in position 7
    • C07D501/16Compounds having a nitrogen atom directly attached in position 7 with a double bond between positions 2 and 3
    • C07D501/207-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids
    • C07D501/247-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids with hydrocarbon radicals, substituted by hetero atoms or hetero rings, attached in position 3
    • C07D501/38Methylene radicals, substituted by nitrogen atoms; Lactams thereof with the 2-carboxyl group; Methylene radicals substituted by nitrogen-containing hetero rings attached by the ring nitrogen atom; Quaternary compounds thereof

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Cephalosporin Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

La présente invention concerne un procédé de préparation du composé de formule (I) dans laquelle X représente un iodo ou un chloro. Le composé de formule (I) est un intermédiaire important dans la préparation de la céfépime ou de ses sels pharmaceutiquement acceptables.
PCT/IB2007/001897 2006-07-18 2007-07-09 Procédé amélioré pour la préparation d'un intermédiaire de la céfépime Ceased WO2008010042A2 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IN1246/CHE/2006 2006-07-18
IN1246CH2006 2006-07-18

Publications (2)

Publication Number Publication Date
WO2008010042A2 WO2008010042A2 (fr) 2008-01-24
WO2008010042A3 true WO2008010042A3 (fr) 2008-06-12

Family

ID=38957140

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/IB2007/001897 Ceased WO2008010042A2 (fr) 2006-07-18 2007-07-09 Procédé amélioré pour la préparation d'un intermédiaire de la céfépime

Country Status (1)

Country Link
WO (1) WO2008010042A2 (fr)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10568328B2 (en) 2013-03-15 2020-02-25 Monsanto Technology Llc Methods and compositions for weed control

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5594131A (en) * 1992-07-24 1997-01-14 Bristol-Myers Squibb Company Process for preparing cephalosporin intermediates
WO2006008749A1 (fr) * 2004-07-16 2006-01-26 Hetero Drugs Limited Procede de preparation d'intermediaires de cephalosporine pures
WO2006075244A2 (fr) * 2005-01-17 2006-07-20 Orchid Chemicals & Pharmaceuticals Ltd Procede ameliore de fabrication d'un intermediaire antibiotique de cephalosporine

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5594131A (en) * 1992-07-24 1997-01-14 Bristol-Myers Squibb Company Process for preparing cephalosporin intermediates
WO2006008749A1 (fr) * 2004-07-16 2006-01-26 Hetero Drugs Limited Procede de preparation d'intermediaires de cephalosporine pures
WO2006075244A2 (fr) * 2005-01-17 2006-07-20 Orchid Chemicals & Pharmaceuticals Ltd Procede ameliore de fabrication d'un intermediaire antibiotique de cephalosporine

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
WALKER D.G. ET AL.: "Use of bistrimethylsilylated intermediates in the preparation of semisynthetic 7-amino-3-substituted cephems. Expedient syntheses of a new 3-[(1-methyl-1-pyrrolidinio)methyl]cephalosporin", J. ORG. CHEM., vol. 53, no. 5, 1988, pages 983 - 991 *

Also Published As

Publication number Publication date
WO2008010042A2 (fr) 2008-01-24

Similar Documents

Publication Publication Date Title
WO2008076046A8 (fr) Nouveaux 2-amino-5, 5-diaryl-imidazol-4-ones
WO2007148185A3 (fr) 3-amino-pyrrolidino-4-lactames substitués
WO2008083248A3 (fr) Analogues de cyclopamine
WO2008022286A3 (fr) petits inhibiteurs moléculaires de la kynurénine-3-monooxygénase
MX2009012168A (es) Derivados de pirrolopiridina y su uso como inhibidores de la enzima que escinde la proteina precursora de amiloide por el sitio beta.
MY147390A (en) Substituted isoindoles as bace inhibitors and their use
TW200728307A (en) Novel spirochromanone derivatives
WO2007103839A3 (fr) Composes de promedicament de pyrrolotriazine aniline utiles en tant qu'inhibiteurs de la kinase
WO2005110410A3 (fr) Inhibiteurs de kinases en tant qu'agents therapeutiques
WO2008013838A3 (fr) Dérivés de pyridizinone
WO2006053255A3 (fr) Nouveaux derives de betuline, preparation de ces derives et utilisation de ces derives
WO2007058583A3 (fr) Composes et leurs utilisations
UA94833C2 (en) Substituted bicyclolactams
WO2008044243A3 (fr) Nouveau procédé de préparation de statines et leurs sels pharmaceutiquement acceptables
WO2007061360A3 (fr) Nouveau composes
WO2008155615A3 (fr) Procédé perfectionné pour la préparation d'un antibiotique de la famille des céphalosporines
WO2007031933A3 (fr) Composition pharmaceutique stable a pyrimidine-sulfamide
WO2008058118A3 (fr) Préparation de montélukast et de ses sels
WO2010097229A3 (fr) Sel amorphe d'un inhibiteur macrocyclique du vhc
WO2010031832A3 (fr) Combinaisons synergiques d'un inhibiteur macrocyclique de hcv et d'un dérivé d'acide thiophène-2-carboxylique
WO2007126900A3 (fr) Agents antifongiques
WO2007014054A3 (fr) Inhibiteur benzenesulfonamide de recepteur de chimiokine ccr2
WO2008001201A3 (fr) Compositions pharmaceutiques de clopidogrel
WO2006113509A3 (fr) Analogues de quinobenzoxazines et procedes d'utilisation de ceux-ci
UA96759C2 (en) 2-ARYLINDOLE DERIVATIVES AS mPGES-I INHIBITORS

Legal Events

Date Code Title Description
NENP Non-entry into the national phase

Ref country code: DE

NENP Non-entry into the national phase

Ref country code: RU

122 Ep: pct application non-entry in european phase

Ref document number: 07804576

Country of ref document: EP

Kind code of ref document: A2